How might Merck redesign the packaging of its Belsomra sleep medication to improve user experience and adherence?

Introduction

To improve the user experience and adherence for Merck's Belsomra sleep medication, we need to redesign its packaging. This task involves understanding the current user experience, identifying pain points, and developing innovative solutions that align with both user needs and Merck's business objectives. I'll approach this challenge systematically, focusing on user segmentation, pain point analysis, solution generation, and measurement strategies.

Step 1

Clarifying Questions

• Looking at the product context, I'm thinking about the specific user demographics for Belsomra. Could you provide more information about the primary user base, such as age range, gender distribution, and typical sleep-related issues they face?

Why it matters: Understanding the user base will help tailor the packaging design to their specific needs and preferences. Expected answer: Primarily adults 45+, slightly more women than men, dealing with chronic insomnia. Impact on approach: Would focus on designs that are easy to read and handle for older adults, potentially with larger text and ergonomic considerations.

• Considering user behavior, I'm curious about the typical usage patterns. How frequently do users take Belsomra, and are there any specific instructions or precautions that need to be prominently displayed on the packaging?

Why it matters: This information will influence the packaging design to support proper usage and safety. Expected answer: Taken nightly, with specific dosage instructions and warnings about driving or operating machinery. Impact on approach: Would prioritize clear dosage instructions and prominent safety warnings in the packaging design.

• Thinking about pain points and market position, how does Belsomra currently compare to competitors in terms of packaging design and user feedback? Are there any specific complaints or praises about the current packaging?

Why it matters: Identifies areas for improvement and potential competitive advantages. Expected answer: Current packaging is functional but unremarkable, with some complaints about difficulty opening for arthritis sufferers. Impact on approach: Would focus on innovative, easy-open designs that could differentiate Belsomra in the market.

• Considering company alignment, what are Merck's key objectives for this redesign? Are we primarily focused on improving adherence, enhancing brand perception, or addressing specific user complaints?

Why it matters: Ensures the redesign aligns with broader company goals and priorities. Expected answer: Primary focus on improving adherence, with secondary goals of enhancing brand perception and addressing user complaints. Impact on approach: Would prioritize design elements that encourage consistent use and make the medication easier to incorporate into daily routines.